US EditionCan B Corp.'s Nascent Pharma Hires Fox Rothschild to Defend and Monetize Its Two Cannabis Patents Valued at $122 Million and Potentially in Excess of $750 Million
Summary by NewMediaWire
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
All
Left
Center
Right
Can B Corp.'s Nascent Pharma Hires Fox Rothschild to Defend and Monetize Its Two Cannabis Patents Valued at $122 Million and Potentially in Excess of $750 Million
HICKSVILLE, NY - April 10, 2025 (NEWMEDIAWIRE) - Can B Corp. (OTCQB: CANB) (“Can B” or the “Company”), through Nascent Pharma Holdings, Inc., is a forward-thinking pharmaceutical Intellectual Property (IP) company focused on maximizing the value of its cannabis patent portfolios, today announced it has retained Fox Rothschild, a U.S. based law firm with 30 offices and 1,000 attorneys. James Smedley, a Partner at Fox Rothschild, will lead the eff…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage
